1 INTRODUCTION  

  1.1    Key Take Aways    
    1.2    Report Description    
    1.3    Markets Covered    
    1.4    Stakeholders    
    1.5    Research Methodology    
        1.5.1    Market Size    
        1.5.2    Market Share    
        1.5.3    Key Data Points From Secondary Sources    
        1.5.4    Key Data Points From Primary Sources

2 Research Methodology

    2.1 Secondary and Primary Research Methodology
           2.1.1 Secondary Research
    2.2 Key Data From Secondary Sources
           2.2.1 Primary Research
    2.3 Key Data From Primary Sources
    2.4 Key Insights From Primary Sources
    2.5 Market Size Estimation Methodology
    2.6 Market forecast Methodology
    2.7 Market Data Validation and Data Triangulation
    2.8 Assumptions

3 Executive Summary

4 Premium Insights

    4.1 Global Synthetic Biology Market to Witness A High Cagr of 24% From 2013 to 2018
    4.2 Synthetic Biology Market, By Region and Application
    4.3 Geographic Snapshot
    4.4 Life Cycle Analysis, By Geography

5 Industry Speaks

    5.1 Demand Side
    5.2 Supply Side

6 Market Overview

    6.1 Introduction
    6.2 Market Dynamics
          6.2.1 Drivers
                   6.2.1.1 Rising R&D Expenditure of Pharmaceutical and Biotechnology Companies
                   6.2.1.2 Increasing Demand for Synthetic Genes
                   6.2.1.3 Rise in the Global Production of Genetically Modified Crops
                   6.2.1.4 Increase in Funding
          6.2.2 Restraint
                   6.2.2.1 Ethical and Societal Issues
          6.2.3 Challenge
                   6.2.3.1 Standardization of Biological Parts
          6.2.4 Opportunities
                   6.2.4.1 Rising Concerns on Fuel Consumption
                   6.2.4.2 Increasing Demand for Protein therapeutics

7 Industry Insights

    7.1 Porter’s Five forces Analysis
          7.1.1 Threat of New Entrants
          7.1.2 Bargaining Power of Suppliers
          7.1.3 Bargaining Power of Buyers
          7.1.4 Segment Rivalry
          7.1.5 Threat of Substitutes

8 Synthetic Biology Market, By Tool

    8.1 Introduction
    8.2 Xeno-Nucleic Acids (Xnas)
    8.3 Chassis Organisms
    8.4 Oligonucleotides
    8.5 Enzymes
    8.6 Cloning Technology Kits

9 Market, By Technology

    9.1 Introduction
          9.1.1 Enabling Technologies
                   9.1.1.1 Gene Synthesis
                   9.1.1.2 Bioinformatics
                   9.1.1.3 Genome Engineering
                   9.1.1.4 Cloning and Sequencing
                   9.1.1.5 Site-Directed Mutagenesis (SDM)
                   9.1.1.6 Measurement and Modeling
                   9.1.1.7 Microfluidics
                   9.1.1.8 Nanotechnology
          9.1.2 Enabled Technologies
                   9.1.2.1 Pathway Engineering
                   9.1.2.2 Next-Generation Sequencing

10 Market, By Application

     10.1 Introduction
             10.1.1 Environmental Applications
                        10.1.1.1 Bioremediation
                        10.1.1.2 Whole-Cell Biosensors
             10.1.2 Medical Applications
                        10.1.2.1 Drug Discovery and therapeutics
                        10.1.2.2 Pharmaceuticals
                        10.1.2.3 Artificial Tissue and Tissue Regeneration
             10.1.3 Industrial Applications
                        10.1.3.1 Biofuel & Renewable Energy
                        10.1.3.2 Industrial Enzymes
                        10.1.3.3 Biomaterials & Green Chemicals

11 Synthetic Biology Market, By Geography

     11.1 Introduction
     11.2 North America
             11.2.1 U.S.
                        11.2.1.1 Government Investments Propelling the Synthetic Biology Market in the U.S.
                        11.2.1.2 Increase in Number of Synthetic Biology Companies and Research Institutes Boosting U.S. Market
             11.2.2 Canada
                        11.2.2.1 Synthetic Biology-Related Conferences and Workshops Promoting Research Activities in Canada
     11.3 Europe
             11.3.1 Europe Prioritizing International Alliances to Boost Synthetic Biology Market
             11.3.2 Heavy Funding for Synthetic Biology Research Likely to Stimulate Market Growth in Europe
             11.3.3 U.K.
                        11.3.3.1 Strong Government Support for Synthetic Biology in the U.K.
             11.3.4 Germany
                        11.3.4.1 Strong Investments Driving the Synthetic Biology Market in Germany
             11.3.5 France
                        11.3.5.1 Rising Awareness to Boost Synthetic Biology Market Growth in France
             11.3.6 Denmark
             11.3.7 Switzerland
                        11.3.7.1 Switzerland Synthetic Biology Market Buoyed By Investments
             11.3.8 Rest of Europe (ROE)
     11.4 Asia
             11.4.1 China
                        11.4.1.1 Collaborations Related to Synthetic Biology Likely to Spur Innovation and Research in Synthetic Biology in China
                        11.4.1.2 Increasing Number of Conferences to Boost Awareness
             11.4.2 Japan
                        11.4.2.1 Established Biotechnology Industry Makes Japan the Leading Asian Country in this Market
             11.4.3 Rest of Asia (ROA)
                        11.4.3.1 Government Investments and Conferences Stimulating the Demand in the ROA
     11.5 Rest of the World (ROW)

12 Competitive Landscape

     12.1 Overview
     12.2 Market Share Analysis
             12.2.1 Introduction
                        12.2.1.1 Thermo Fisher Scientific, Inc. (U.S.)
                        12.2.1.2 Royal DSM N.V. (Netherlands)
                        12.2.1.3 Dupont (U.S.)
     12.3 Competitive Situation and Trends
     12.4 Agreements, Partnerships, Collaborations, and Joint Ventures
     12.5 New Product Launches
     12.6 Expansions
     12.7 Acquisitions
     12.8 Others